TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
160
|
115
|
24 |
| Financial expenses |
3
|
2
|
0 |
| Earnings before taxes |
12
|
19
|
-9 |
| EBITDA |
9
|
22
|
-8 |
| Total assets |
47
|
39
|
11 |
| Current assets |
36
|
27
|
7 |
| Current liabilities |
47
|
32
|
12 |
| Equity capital |
1
|
7
|
-13 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
2.1%
|
17.9%
|
-118.2% |
| Turnover per employee |
80
|
58
|
12 |
| Profit as a percentage of turnover |
7.5%
|
16.5%
|
-37.5% |
| Return on assets (ROA) |
31.9%
|
53.8%
|
-81.8% |
| Current ratio |
76.6%
|
84.4%
|
58.3% |
| Return on equity (ROE) |
1200%
|
271.4%
|
69.2% |
| Change turnover |
44
|
93
|
-21 |
| Change turnover % |
38%
|
416%
|
-46% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.